Nov. 15, 2002 — Tm Bioscience Corp., a Toronto microarray developer, closed on a little less than $3 million in debt financing with Canadian Medical Discoveries Fund Inc., according to a news release.
The secured loan is intended to help Tm Bioscience complete the development and commercialization of its first series of genetic tests, the release said. Canadian Medical Discoveries Fund owns slightly less than 21 percent of Tm Bioscience.